"PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to ... SBWire (press release) Boston, MA -- (SBWIRE) -- 08/15/2013 -- GlobalData has released its new Country report, "PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022". The chronic heart failure (CHF) market is a mature market that has been slowly ... |
